2021年6月9日，备受血液学领域瞩目的第26届欧洲血液学协会（EHA）年会将如期而至。本次EHA与2020年同样采取了线上虚拟网络会的模式。北京时间5月12日23:00，大会摘要公布。小编第一时间检索出16篇中国专家在本届EHA的口头发言，以供大家参考。（按摘要号排列先后）
北京大学人民医院张晓辉教授团队：一种β2肾上腺素能受体激动剂纠正原发性免疫性血小板减少症辅助性T细胞极化失调
标题：A Β2 ADRENERGIC RECEPTOR AGONIST CORRECTS DYSREGULATED POLARIZATION OF T HELPER CELLS IN PRIMARY IMMUNE THROMBOCYTOPENIA
作者：Gaochao Zhang , Fengqi Liu , Yan Su , Yun He , Xiaolu Zhu , Haixia Fu , Xiaosu Zhao , Xiangyu Zhao , Yingjun Chang , Xiaohui Zhang
摘要号：S104（主席研讨会）
高博医疗北京博仁医院潘静主任团队：供体来源CD7 CAR-T细胞治疗急性T淋巴细胞白血病
标题：DONOR-DERIVED CD7 CAR T CELLS FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
作者： Jing Pan , Yue Tan , Biping Deng , Zhuojun Ling , Weiliang Song , Jinlong Xu , Jiajia Duan , Zelin Wang , Alex H. Chang , Xiaoming Feng
摘要号：S115
陆道培医院陆佩华教授团队：新型CD19/CD20合成T细胞受体和抗原受体（STAR)-T细胞治疗难治/复发性（R/R）急性B淋巴细胞白血病（B-ALL）
标题：A NOVEL CD19/CD20 DUAL SYNTHETIC T-CELL RECEPTOR AND ANTIGEN RECEPTOR (STAR) T CELL THERAPY FOR REFRACTORY AND RELAPSED (R/R) B CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
作者：Junfang Yang , Jiasheng Wang , Xian Zhang , Jingjing Li , Li Yu , Zhixiao Zhou , Lemei Jia , Yue Liu , Hongli Zheng , Xin Lin , Peihua Lu
摘要号：S118
高博医疗北京博仁医院潘静主任团队：序贯CD19-22 CAR-T细胞治疗难治/复发性B-ALL 20例患者的远期随访结果
标题：LONG-TERM FOLLOW-UP OF SEQUENTIAL CD19-22 CAR T-CELL THERAY IN 20 CHILDREN WITH REFRACTORY OR RELAPSED B-ALL
作者：Jing Pan , Kaiting Tang , Biping Deng , Zhuojun Ling , Weiliang Song , Alex H. Chang
摘要号：S119
中国医学科学院血液病医院邱录贵教授团队、华中科技大学同济医学院附属同济医院周剑峰教授团队：新型全人源BCMA靶向CAR-T细胞治疗（CT103A）复发/难治性多发性骨髓瘤的I期研究结果
标题：AN UPDATED PHASE 1 STUDY OF A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS (CT103A) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
作者：Chunrui Li , Di Wang , Jue Wang , Zhenyu Li , He Huang , Jing Liu , Yongping Song , Xi Zhang , Dehui Zou , Li Gao , Yongxian Hu , Ai-ning Xu , Wen Wang , Liting Chen , Li Zhu , Ming Wu , Jie Zhang , Jianfeng Zhou , Lugui Qiu
摘要号：S194
浙江大学医学院附属第一医院金洁教授团队：新型JAK抑制剂JAKTINIB治疗晚期骨髓纤维化：II期研究的初步结果
标题：JAKTINIB, A NOVAL JAK INHIBITOR IN TREATMENT OF PATIENTS WITH ADVANCED MYELOFIBROSIS: PRELIMINARY RESULTS FROM A PHASE 2 STUDY
作者：Yi Zhang , Hu Zhou , Zhong-Xing Jiang , Deng-Shu Wu , Jun-Ling Zhuang , Li Wei , Qian Jiang , Xiu-Li Wang , Jin-Wen Huang , Huan-Ling Zhu , Rui-Juan Zhang , Xin Du , Fei Li , Rui-Xiang Xia , Feng Zhang , Jian-Da Hu , Yan Li , Yu Hu , Jing Liu , Cheng-Hao Jin , Kai Sun , Ze-Ping Zhou , Jie Jin
摘要号：S204
北京大学肿瘤医院朱军教授、江苏省肿瘤医院冯继锋和吴剑秋教授等团队：卡瑞利珠单抗治疗复发或难治性经典型霍奇金淋巴瘤：多中心II期研究的3年结果
标题：CAMRELIZUMAB FOR RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: THREE-YEAR OUTCOME OF A MULTICENTER, PHASE 2 STUDY
作者：Jianqiu Wu , Yuqin Song , Xinchuan Chen , Tongyu Lin , Junning Cao , Yanyan Liu , Yaozhong Zhao , Jie Jin , Haiwen Huang , Jianda Hu , Jun Luo , Liling Zhang , Hongwei Xue , Qingyuan Zhang , Weiwei Wang , Chunxia Chen , Jifeng Feng , Jun Zhu
摘要号：S206
北京大学肿瘤医院朱军教授团队：替雷利珠单抗（BGB-A317）治疗复发/难治性经典型霍奇金淋巴瘤：II期研究的长期随访疗效和安全性结果
标题：TISLELIZUMAB (BGB-A317) FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: LONG-TERM FOLLOW-UP EFFICACY AND SAFETY RESULTS FROM A PHASE 2 STUDY
作者：Yuqin Song , Quanli Gao , Huilai Zhang , Lei Fan , Jianfeng Zhou , Dehui Zou , Wei Li , Haiyan Yang , Ting Liu , Quanshun Wang , Fangfang Lv , Haiyi Guo , Xia Zhao , Jane Huang , William Novotny , Yidi Wang , Jun Zhu
摘要号：S207
高博医疗北京博仁医院克晓燕主任团队：复发难治性DLBCL的遗传学图谱及CAR-T细治疗的疗效观察
标题：GENETIC LANDSCAPES AND CURATIVE EFFECT OF CAR T CELLS IMMUNOTHERAPY IN RELAPSE AND REFRACTORY DLBCLS
作者：Hui Shi , Peihao Zheng , Kai Hu , Xiaoyan Ke
摘要号：S217
北京协和医院周道斌教授团队：来那度胺、利妥昔单抗、大剂量甲氨蝶呤（R2-MTX）方案后来那度胺维持治疗新诊断原发性中枢神经系统淋巴瘤的IB/II期研究结果
标题：PHASE IB/II STUDY OF LENALIDOMIDE, RITUXIMAB, HIGH-DOSE METHOREXATE (R2-MTX) REGIMEN, FOLLOWED BY LENALIDOMIDE MAINTAINANCE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA
作者：Yan Zhang , Wei Wang , Wei Zhang , Daobin Zhou
摘要号：S223
山东省立医院王欣教授团队：阻断NCAPD3有望作为治疗弥漫性大B细胞淋巴瘤的新方法
标题：BLOCKADE OF NCAPD3 AS A NOVEL THERAPEUTIC APPROACH IN DIFFUSE LARGE B-CELL LYMPHOMA
作者：Juan Yang , Xiangxiang Zhou , Shunfeng Hu , Yiqing Cai , Jiarui Liu , Shuai Ren , Xiaomin Chen , Xin Wang
摘要号：S228
山东大学齐鲁医院彭军教授团队：单细胞RNA测序鉴定免疫性血小板减少症造血干细胞和祖细胞的特征
标题：FEATURES OF HEMATOPOIETIC STEM AND PROGENITOR CELLS IDENTIFIED THROUGH SINGLE-CELL RNA SEQUENCING IN IMMUNE THROMBOCYTOPENIA
作者：彭军教授团队Yan Liu , Anli Liu , Jun Peng
摘要号：S297
北京大学人民医院张晓辉教授团队：高水平雌二醇诱导免疫性血小板减少症患者孕期巨核细胞凋亡及通过MST1-FOXO1轴抑制血小板形成
标题：HIGH LEVEL OF ESTRADIOL INDUCES MEGAKARYOCYTE APOPTOSIS AND IMPAIRS PROPLATELET FORMATION VIA MST1-FOXO1 AXIS DURING PREGNANCY IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA
作者：Qi Chen , Feng-qi Liu , Xue-yan Sun , Chen-cong Wang , Xiao-lu Zhu , Yun He , Mei-ying Liang , Jian-liu Wang , Xiao-Hui Zhang
摘要号：S298
北京大学人民医院黄晓军教授团队：通过上调PI3K-AKT途径恢复M1/M2巨噬细胞极化减轻同种异体移植后长期孤立性血小板减少症
标题：RESTORING M1/M2 MACROPHAGE POLARIZATION VIA UP-REGULATING PI3K-AKT PATHWAY ALLEVIATES PROLONGED ISOLATED THROMBOCYTOPENIA POST-ALLOTRANSPLANT
作者：Hong-Yan Zhao , Yuan-Yuan Zhang , Tong Xing , Shu-Qian Tang , Qi Wen , Zhong-Shi Lyu , Meng Lv , Yu Wang , Lan-Ping Xu , Xiao-Hui Zhang , Yuan Kong , Xiao-Jun Huang
摘要号：S230
北京大学人民医院张晓辉教授团队：双硫仑通过抑制巨噬细胞焦亡减轻急性移植物抗宿主病
标题：DISULFIRAM ALLEVIATES ACUTE GRAFT-VERSUS-HOST DISEASE BY INHIBITING MACROPHAGE PYROPTOSIS
作者：Xue-Yan Sun , Yan Su , Fengqi Liu , Qi Chen , Xiao-Jun Huang , Xiao-Hui Zhang
摘要号：S231
北京大学人民医院黄晓军、常英军教授团队：一个主要基于最小可测量残留病定量动力学的综合评分系统，用于预测急性淋巴细胞白血病患者的复发
标题：AN INTEGRATIVE SCORING SYSTEM MAINLY BASED ON QUANTITATIVE DYNAMICS OF MINIMAL/MEASURABLE RESIDUAL DISEASE FOR RELAPSE PREDICTION IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
作者：Rui Ma , Lan-Ping Xu , Xiao-Hui Zhang , Yu Wang , Huan Chen , Yu-Hong Chen , Feng-Rong Wang , Wei Han , Yu-Qian Sun , Chen-Hua Yan , Fei-Fei Tang , Xiao-Dong Mo , Yan-Rong Liu , Kai-Yan Liu , Xiao-Jun Huang , Ying-Jun Chang
摘要号：S234
如有遗漏，欢迎留言补充，谢谢！
排版编辑：Amiee
苏公网安备32059002004080号
